取消

NIBSC 67/099免疫球蛋白 IgG IgA IgM Immunoglobulins G, A

上海柯维化学技术有限公司
所在地:上海 上海
最新产品 进入店铺
  • 详情
  • 联系方式

3月8号  03/124 微博

上海柯维化学技术有限公司

电话:021-64609169、18321124657

QQ:1054713992

邮箱:1054713992@qq.com

网址:www.kewelchem.com

Immunoglobulins and immune sera  免疫球蛋白和免疫血清

Product Number

Description

07/164

Anti-HBs immunoglobulin (2nd International Standard)
WHO International Standard or Reference Reagent

11/234

Immunoglobulin E (IgE), human serum (3rd International Standard)
WHO International Standard or Reference Reagent

64/002

Rheumatoid Arthritis Serum
Non WHO Reference Material

66/233

Anti-Nuclear Factor Serum (Homogenous) Human
Non WHO Reference Material

67/037

Immunoglobulin D (IgD) Serum, Human
Non WHO Reference Material

67/086

Immunoglobulins G, A, M Serum Human (International Standard)
WHO International Standard or Reference Reagent

67/099

Immunoglobulins G, A & M Serum Human
Non WHO Reference Material

67/183

Primary Biliary Cirrhosis Serum, Human
Non WHO Reference Material

68/340

Anti-Nucleolar Factor Plasma, Human
Non WHO Reference Material

69/065

Autoimmune Antibody to Human Spermatazoa
Non WHO Reference Material

76/525

Anti-Birch Pollen Serum, Human
Non WHO Reference Material

77/503

Anti-Cocksfoot Serum, Human
Non WHO Reference Material

77/584

Anti-D Pteronyssinus Serum, Human
Non WHO Reference Material

78/545

Anti-Aspergillus fumigatus Serum, Human
Non WHO Reference Material

85/551

Anti-Rye Grass Serum, Human
Non WHO Reference Material

90/690

Anti-Varicella-Zoster Antibody
CE Marked Material

97/646

Anti-Hepatitis A Immunoglobulin, Human (W1041)
WHO International Standard or Reference Reagent

RAI

Anti-rabies Immunoglobulin, Human
WHO International Standard or Reference Reagent

TILI

Anti-tick borne encephalitis serum
WHO International Standard or Reference Reagent

TISA

Anti-tick borne encephalitis serum
WHO International Standard or Reference Reagent

W1044

Anti-Varicella zoster immunoglobulin
WHO International Standard or Reference Reagent

W1062

Anti smooth muscle(anti actin) autoantibody.
WHO International Standard or Reference Reagent

W1063

Anti nuclear ribonucleoprotein(nRNP) autoantibody
WHO International Standard or Reference Reagent

W1064

Anti-Nuclear factor serum,homogenous(66/233)
Non WHO Reference Material

W1066

Rheumatoid Arthritis serum.
WHO International Standard or Reference Reagent



007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)

WHO International Standard

01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody

Non WHO Reference Material

01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)

International Reference Reagent

01/424 Vascular Endothelial Growth Factor, Human rDNA derived

Non WHO Reference Material

01/426 Meningococcal group Y polysaccharide

Non WHO Reference Material

01/428 Meningococcal serogroup W polysaccharide

Non WHO Reference Material

01/450 Influenza anti B/Guangdong/120/2000 Serum

Influenza Reagent

01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum

Influenza Reagent

01/506 Botulinum type F antitoxin, equine

Non WHO Reference Material

01/508 Botulinum type C antitoxin, equine

Non WHO Reference Material

01/510 Botulinum Antitoxin Equine Type D

Non WHO Reference Material

01/512 Botulinum type G antitoxin, equine

Non WHO Reference Material

01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody

Non WHO Reference Material

01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)

International Reference Preparation

01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)

International Reference Preparation

01/538 Anti-Meningococcal Serosubtype P1.16 mAb

Non WHO Reference Material

01/546 Influenza Antigen B/Guangdong/120/2000

Influenza Reagent

01/572 Anti-D Immunoglobulin(2nd International Standard)

WHO International Standard

01/580 Thrombin, human(2nd International Standard)

WHO International Standard

01/600 Anti-Toxoplasma IgG, Human(International Standard)

WHO International Standard

01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)

WHO International Standard

01/612 Influenza Virus infectious B/Hawaii/10/01

Influenza Reagent

01/614 Influenza Antigen A/New Caledonia/20/99

Influenza Reagent

02/102 Influenza anti A/Panama/2007/99 Serum

Influenza Reagent

02/144 Anti-Meningococcal Serosubtype P1.15 mAb

Non WHO Reference Material

02/148 Anti-Meningococcal Serosubtype P1.4 mAb

Non WHO Reference Material

02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)

WHO International Standard

02/178 Anti-Meningococcal Serosubtype P1.2 mAb

Non WHO Reference Material

02/180 Anti-Meningococcal Serotype P2.2a mAb

Non WHO Reference Material

02/182 Anti-Japanese Encephalitis Virus Plasma, Human

Non WHO Reference Material

02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human

Non WHO Reference Material

02/206 Factor XIII Plasma, Human (1st International Standard)

WHO International Standard

02/210 HIV (antibody), 1st International Reference Panel

International Reference Preparation

02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)

International Reference Reagent

02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)

International Reference Reagent

02/230 Biotinylated Brad-5 (Bio-Brad-5)

Working Standard

02/232 Tetanus Toxoid (Non-Adsorbed)

Non WHO Reference Material

02/254 Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)

WHO International Standard

02/262 Influenza Virus infectious B/Brisbane/32/2002

Influenza Reagent

02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)

International Reference Reagent

02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)

Influenza Reagent

02/308 Anti-Meningococcal Serotype P3.4 mAb

Non WHO Reference Material

02/310 Anti-Meningococcal Serotype P3.15 mAb

Non WHO Reference Material

02/318 Botulinum Antitoxin Equine Type E

Non WHO Reference Material

02/320 Anti-Meningococcal Serosubtype P1.3 mAb

Non WHO Reference Material

02/336 Influenza Antigen A/New Caledonia/20/99

Influenza Reagent

02/338 Influenza anti A/Panama/2007/99 Serum

Influenza Reagent

02/342 Protein C Plasma, Human(2nd International Standard)

WHO International Standard

03/104-018 HTLV-1 (antibody) Monitor Sample

CE Marked Material

03/110 Influenza anti B/Shangdong/9/97 Serum

Influenza Reagent

03/114 Anti-Meningococcal Serosubtype P1.1 mAb

Non WHO Reference Material

03/116 Blood Coagulation Factor V, Plasma Human (1st International Standard)

WHO International Standard

03/124 Thrombopoietin ( Human rDNA derived)

Non WHO Reference Material

03/142 Anti-Meningococcal Serosubtype P1.14 mAb

Non WHO Reference Material

03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)

International Reference Reagent

03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)

International Reference Reagent

03/152 Anti-HPA-1a (International Standard)

WHO International Standard

03/164 Anti-B minimum potency reference preparation(International Standard)

WHO International Standard

03/178 Vitamin B12, Serum Folate and holoTC (International standard)

WHO International Standard

03/182 Anti-Meningococcal Serotype P3.21 mAb

Non WHO Reference Material

03/188 Anti-A minimum potency reference preparation(International Standard)

WHO International Standard

03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)

International Reference Reagent

03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)

WHO International Standard

03/198 Influenza Virus infectious A/Kumamoto/102/02

Influenza Reagent

03/200 Interleukin - 18 (Human rDNA derived)(International Reference Reagent)

International Reference Reagent

03/210 Anti-Meningiococcal Serosubtype P1.6 mAb

Non WHO Reference Material

03/212 Influenza anti A/Wyoming/03/03 Serum

Influenza Reagent

03/220 Influenza Antigen A/Wyoming/03/03

Influenza Reagent

03/224 Anti-Meningococcal Serosubtype P1.10 mAb

Non WHO Reference Material

03/226 Anti-Meningococcal Serosubtype P1.5 mAb

Non WHO Reference Material

03/228 Protein S, Plasma, Human(2nd International Standard)

WHO International Standard

03/236 Anti-Meningococcal Serosubtype P1.13 mAb

Non WHO Reference Material

03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum

Influenza Reagent

03/244 Influenza Antiserum A/chick/Germany/N/49

Influenza Reagent

03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)

Influenza Reagent

03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)

International Reference Preparation

04/122 Anti-Meningococcal Serosubtype P1.12 mAb

Non WHO Reference Material

04/140 IVIG Negative Control for use with IVIG & Anti-D

Non WHO Reference Material

04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)

WHO International Standard

04/160 Influenza Virus infectious NYMC X-147

Influenza Reagent

04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)

WHO International Standard

04/170 Influenza Virus infectious A/Wellington/1/2004

Influenza Reagent

04/172 Influenza Virus infectious IVR-139

Influenza Reagent

04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)

WHO International Standard

04/198 Anti-Meningococcal Serotype P3.1 mAb

Non WHO Reference Material

04/202 Influenza Antigen B/ Jiangsu/10/2003

Influenza Reagent

04/214 Influenza Antiserum A/Viet Nam/1194/04 (H5N1)

Influenza Reagent

04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004

WHO International Standard

04/228 Influenza anti B/ Neuraminidase Serum

Influenza Reagent

04/242 Influenza anti B/Jiangsu/10/2003 HA Serum

Influenza Reagent

04/246 Anti-Meningococcal Serogroup W-135 mAb

Non WHO Reference Material

04/248 Anti-Meningococcal Serosubtype P1.19 mAb

Non WHO Reference Material

04/252 Protein C Concentrate, Human(1st International Standard)

WHO International Standard

04/260 Influenza anti A/New Caledonia/20/99 HA Serum

Influenza Reagent

04/262 Influenza anti A/New York/55/2004 HA Serum

Influenza Reagent

04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)

Influenza Reagent

05/102 Influenza Virus infectious NYMC BX-7

Influenza Reagent

05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)

International Reference Reagent

05/110 Influenza Virus infectious A/California/7/2004

Influenza Reagent

05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).

WHO International Standard

05/122 Syphilitic plasma IgG (human)(1st International Standard)

WHO International Standard

05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)

WHO International Standard

05/134 Anti-human papillomavirus type 16 serum (1st International Standard)

WHO International Standard

05/138 Influenza Virus infectious B/Shanghai/361/2002

Influenza Reagent

05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)

WHO International Standard

05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody

Non WHO Reference Material

05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody

Non WHO Reference Material

05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)

Influenza Reagent

05/236 Influenza anti A/Wisconsin/67/2005 Serum

Influenza Reagent

05/242 IVIG, Anti-D and Negative Control Panel

Non WHO Reference Material

05/252 Influenza anti B Neuraminidase Serum

Influenza Reagent

06/108 Influenza Virus infectious IVR-116

Influenza Reagent

06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)

WHO International Standard

06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)

WHO International Standard

06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.

WHO International Standard

06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent

International Reference Reagent

06/164 Influenza Virus infectious 1 VR-142

Influenza Reagent

06/166 Antithrombin Concentrate, Human (3rd International Standard)

WHO International Standard

06/170 Influenza Antigen A/New Caledonia/20/99

Influenza Reagent

06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)

Influenza Reagent

06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)

WHO International Standard

06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)

WHO International Standard

06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)

Influenza Reagent

07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)

Influenza Reagent

07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum

Influenza Reagent

07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23

Influenza Reagent

07/132 Influenza Virus infectious B/Malaysia/2506/2004

Influenza Reagent

07/144 Influenza Virus infectious IVR-145,

Influenza Reagent

07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)

Influenza Reagent

07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum

Influenza Reagent

07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)

WHO International Standard

07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)

WHO International Standard

07/184 Influenza anti B/Malaysia/2506/2004-HA Serum

Influenza Reagent

07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)

International Reference Reagent

07/204 Influenza Virus Infectious NIBRG-60 VE2 25820

Influenza Reagent

07/214 Positive Control for use in flow cytometry cross matching (FCXM)

CE Marked Material

07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)

WHO International Standard

07/222 RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)

International Reference Reagent

07/226 Influenza Virus Infectious A/New Caledonia/20/99

Influenza Reagent

07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”

WHO International Standard

07/246 Influenza Virus Infectious IVR-147

Influenza Reagent

07/268 Influenza Virus Infectious B/Brisbane/3/2007

Influenza Reagent

07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)

International Reference Reagent

07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)

International Reference Reagent

07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)

International Reference Reagent

07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)

Influenza Reagent

07/286-014 0.05 IU HBsAg Monitor Sample

CE Marked Material

07/288-016 Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml

CE Marked Material

07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6

Influenza Reagent

07/296-006 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

07/298-006 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

07/300-006 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

07/304 Anti-D for assuring operator and test performance

Working Standard

07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)

International Reference Reagent

07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)

WHO International Standard

07/318 Meningococcal Group C Polysaccharide

Non WHO Reference Material

07/328 Unfractionated Heparin (6th I.S.)

WHO International Standard

07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60

Influenza Reagent

07/338 Influenza antiserum A/Anhui/1/05 (H5)

Influenza Reagent

07/348 Influenza Virus infectious NYMC X-171B

Influenza Reagent

07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)

WHO International Standard

07/358 Influenza Virus infectious NIB-50

Influenza Reagent

07/362 Influenza Virus infectious IVR-149

Influenza Reagent

07/364 Chorionic Gonadotrophin, (5th IS)

WHO International Standard

07/B498-19 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1

Quality Control Reagent

08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)

Influenza Reagent

08/108 Influenza Virus Infectious NIBRG-91

Influenza Reagent

08/118-005 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/120-006 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/126 Influenza Anti N1 Neuraminidase Serum SH485

Influenza Reagent

08/138 Influenza Virus Infectious B/Florida/4/2006

Influenza Reagent

08/140 Influenza Antigen B/Florida/4/2006

Influenza Reagent

08/142 Influenza antiserum A/Anhui/1/05 (H5)

Influenza Reagent

08/148 Positive control for Luminex based anti-HLA Class II serology

CE Marked Material

08/150 HIV-2 RNA(1st International Standard)

WHO International Standard

08/154 Influenza Virus Infectious NIBRG-12

Influenza Reagent

08/156 Influenza Virus Infectious NIBRG-23 30060 VE3

Influenza Reagent

08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)

WHO International Standard

08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)

WHO International Standard

08/174-008 Human Coxsackie B4 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/176-005 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/178-005 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/180-005 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

08/184 Influenza Antigen B/Malaysia/2506/2004

Influenza Reagent

08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)

Influenza Reagent

08/204 Thyroid Stimulating Antibody (2nd I.S.)

WHO International Standard

08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)

Influenza Reagent

08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)

Influenza Reagent

08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)

WHO International Standard

08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)

Influenza Reagent

08/218 Tetanus Toxoid Adsorbed (4th International Standard)

WHO International Standard

08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91

Influenza Reagent

08/230 Streptodornase (2nd International Standard)

WHO International Standard

08/246 Influenza anti A/Brisbane/10/2007- like HA serum

Influenza Reagent

08/256 C1- Inhibitor, Concentrate (1st International Standard)

WHO International Standard

08/258 Antithrombin, Plasma (3rd International Standard)

WHO International Standard

08/262 C1 Inhibitor (Plasma)(1st International Standard)

WHO International Standard

08/266 Sex Hormone Binding Globulin.(2nd International Standard)

WHO International Standard

08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107

Influenza Reagent

08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))

Influenza Reagent

08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)

WHO International Standard

08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5

Influenza Reagent

08/300 Influenza Virus Infectious IVR-148

Influenza Reagent

08/304 Influenza virus infectious NYMC X-175C

Influenza Reagent

08/318-007 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing

Clinical Virology Network CVN

08/320-007 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing

Clinical Virology Network CVN

08/322-006 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing

Clinical Virology Network CVN

08/324-005 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing

Clinical Virology Network CVN

08/356 Influenza antiserum A/Japan/305/57 (H2)

Influenza Reagent

08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109

Influenza Reagent

09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)

Influenza Reagent

09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)

WHO International Standard

09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology

CE Marked Material

09/130 Influenza Virus Infectious NIBRG-122

Influenza Reagent

09/132-004 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing

Clinical Virology Network CVN

09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)

WHO International Standard

09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)

WHO International Standard

09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)

WHO International Standard

09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)

Influenza Reagent

09/154 Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)

WHO International Standard

09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)

WHO International Standard

09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody

Non WHO Reference Material

09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)

WHO International Standard

09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)

Influenza Reagent

09/182 VWF Factor Concentrate (2nd International Standard)

WHO International Standard

09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14

Influenza Reagent

09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)

WHO International Standard

09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)

WHO International Standard

09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)

Influenza Reagent

09/222 Human anti-Haemophilus influenzae b reference serum

CE Marked Material

09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-? 3) (1st International Standard)

WHO International Standard

09/236 Influenza Virus Infectious IVR-153

Influenza Reagent

09/242 Fibrinogen Concentrate (B)(2nd International Standard)

WHO International Standard

09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)

WHO International Standard

09/264 Fibrinogen Plasma (D)(3rd International Standard)

WHO International Standard

09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived

Non WHO Reference Material

09/268 Influenza Virus Infectious NIBRG-121xp

Influenza Reagent

09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)

Non WHO Reference Material

09/274 Influenza Virus Infectious NYMC X-185

Influenza Reagent

09/280 Influenza Virus Infectious NIB-64

Influenza Reagent

09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent

International Reference Reagent

09/296 Pro-Insulin, human (1st International Standard)

WHO International Standard

09/304 Influenza Virus Infectious IVR-155

Influenza Reagent

09/306 Influenza Virus Infectious NIBRG-147

Influenza Reagent

09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay

Working Standard

09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)

Influenza Reagent

09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)

Influenza Reagent

09/B584-15 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

Quality Control Reagent

10/104 Reteplase Reference Material

Non WHO Reference Material

10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum

Influenza Reagent

10/128 Diphtheria Polyclonal Antibody

Non WHO Reference Material

10/130 Diphtheria Monoclonal Antibody

Non WHO Reference Material

10/132 Tetanus Polyclonal Antibody

Non WHO Reference Material

10/134 Tetanus Monoclonal Antibody

Non WHO Reference Material

10/136-001 HLA-DRB1 Genotyping Reference Panel

CE Marked Material

10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)

WHO International Standard

10/142 Negative control for Luminex based anti-HLA serology

CE Marked Material

10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].

International Reference Reagent

10/168 Oral Poliovaccine Sabin Type 3 reference

International Reference Reagent

10/176 Interleukin-29 (Interferon Lamda 1)

International Reference Reagent

10/178 Endotoxin (3rd International Standard)

WHO International Standard

10/188 Factor VIII Concentrate (13th British Standard).

Working Standard

10/198 Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)

International Reference Reagent

10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)

WHO International Standard

10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396

Influenza Reagent

10/218 Influenza Anti A/California/7/2009 (N1) NA Serum

Influenza Reagent

10/226 Influenza Virus Infectious IVR-158

Influenza Reagent

10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)

International Reference Reagent

10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)

International Reference Reagent

10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)

International Reference Reagent

10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)

International Reference Reagent

10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)

WHO International Standard

10/252 Factor VII Concentrate(2nd International Standard)

WHO International Standard

10/258 Influenza Antigen A/California/7/2009-like(NIB-74)

Influenza Reagent

10/262 Diphtheria Antitoxin Human IgG(1st International Standard)

WHO International Standard

10/266 4th WHO International Standard for HBV DNA for NAT

WHO International Standard

10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)

International Reference Reagent

10/280 Anti-HLA Control

CE Marked Material

10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)

WHO International Standard

10/B596-11 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1

Quality Control Reagent

1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)

Non WHO Reference Material

11/106 Influenza Virus infectious A/Perth/16/2009

Influenza Reagent

11/108 Influenza Virus infectious NYMC X-187

Influenza Reagent

11/126 Factors II and X Concentrate (4th International standard)

WHO International Standard

11/130 Influenza Virus Infectious NIBRG-14

Influenza Reagent

11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)

Influenza Reagent

11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)

WHO International Standard

11/176 (3rd International Standard) Low Molecular Weight Heparin

WHO International Standard

11/184 High Molecular Weight Urokinase(2nd International Standard)

WHO International Standard

11/206 Influenza anti-A/Perth/16/2009 HA Serum

Influenza Reagent

11/210 Anti-human CD4 FITC conjugated 0.5ml

CE Marked Material

11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)

International Reference Reagent

11/216 Chagas Antibody Reference Panel ( 1st International Standard)

WHO International Standard

11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel

CE Marked Material

11/222 Influenza Virus Infectious NIB-79

Influenza Reagent

11/226 Influenza Virus Infectious A/Victoria/361/2011

Influenza Reagent

11/232 Influenza Virus Infectious B/Texas/6/2011

Influenza Reagent

11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)

WHO International Standard

11/242-001 Viral Multiplex Reference

Non WHO Reference Material

11/244 Influenza Virus Infectiious NYMC BX-49

Influenza Reagent

11/B604-02 QCRFLUAH5QC1 Influenza H5 PC1

Quality Control Reagent

11/B606-07 QCRNEGQC1-Negative Quality Control Serum: Sample1

Quality Control Reagent

11/B608-03 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1

Quality Control Reagent

12/100 Influenza Virus Infectious NYMC X-217

Influenza Reagent

12/104 International Standard for IPV 12/104 (3rd International Standard)

WHO International Standard

12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)

Influenza Reagent

12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)

Influenza Reagent

12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)

Influenza Reagent

12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)

Influenza Reagent

12/116 Influenza anti-A/Victoria/361/2011-like HA serum

Influenza Reagent

12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum

Influenza Reagent

12/122 Influenza virus infectious A/turkey/Italy/3889/1999

Influenza Reagent

12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)

WHO International Standard

12/176 Methylated Human Serum Albumin (mHSA)

Non WHO Reference Material

12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard)

WHO International Standard

12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5

Influenza Reagent

12/202 Influenza virus infectious NYMC BX-39

Influenza Reagent

12/204 Influenza Virus infectious IVR-165

Influenza Reagent

12/208 Parvovirus B19 (3rd International Standard)

WHO International Standard

12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)

International Reference Preparation

12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

WHO International Standard

12/244 Vi polysaccharide of C freundii WHO 1st International Standard

WHO International Standard

12/252 ADAMTS 13 Plasma (1st International Standard)

WHO International Standard

12/282 Diphtheria Toxin 1Lf/ml

Non WHO Reference Material

12/284 Anti-meningococcal serogroup Y monoclonal antibody

Non WHO Reference Material

12/290 Influenza Virus Infectious B/Brisbane/36/2012

Influenza Reagent

12/294 Influenza Virus Infectious NYMC BX-51C

Influenza Reagent

12/298 Influenza Virus Infectious A/Texas/50/2012

Influenza Reagent

12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)

WHO International Standard

12/B611-03 Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1

Quality Control Reagent

12/B612-05 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1

Quality Control Reagent

12/B613-06 QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2

Quality Control Reagent

12/B623-04 QCRFLUAH1N1QC1-Influenza AH1N1 QC1

Quality Control Reagent

13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)

WHO International Standard

13/106 Influenza Antigen B/Massachusetts/02/2012

Influenza Reagent

13/108 Anti-Meningococcal serogroup B monoclonal antibody

Non WHO Reference Material

13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)

Influenza Reagent

13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)

Influenza Reagent

13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)

WHO International Standard

13/126 Influenza anti-B/Brisbane/60/2008-like HA serum

Influenza Reagent

13/128 Influenza Virus Infectious NIBRG-269

Influenza Reagent

13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard).

WHO International Standard

13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

Influenza Reagent

13/146 C-Peptide, Human (1st International Standard).

WHO International Standard

13/152 Influenza Antigen B/Massachusetts/02/2012 (cell derived)

Influenza Reagent

13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)

Influenza Reagent

13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)

Influenza Reagent

13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum

Influenza Reagent

13/168-002 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

13/172 Lupus Anticoagulant (1st International Reference Panel)

International Reference Preparation

13/176 Influenza Virus Infectious NIBRG-88

Influenza Reagent

13/178 Influenza Anti-A/Texas/50/2012-like HA Serum

Influenza Reagent

13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum

Influenza Reagent

13/198 Influenza Virus Infectious NYMC X-181

Influenza Reagent

13/200 Influenza Virus Infectious NIB-74

Influenza Reagent

13/202 Influenza Virus Infectious NIB-74xp

Influenza Reagent

13/204 TNF Rec II- FC Fusion protein (1st International Standard)

WHO International Standard

13/206 Plasmin (4th International Standard)

WHO International Standard

13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)

WHO International Standard

13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)

International Reference Preparation

13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal

Non WHO Reference Material

13/218 Polio Anti Sabin type 1 (inactivated) Serum

Non WHO Reference Material

13/220 Polio Anti Sabin type 2 (inactivated) serum

Non WHO Reference Material

13/222 Polio Anti Sabin type 3 (inactivated) serum

Non WHO Reference Material

13/224 Influenza virus Infectious NIB-85. 36210 E5

Influenza Reagent

13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4

Influenza Reagent

13/234 Influenza antigen B/Brisbane/60/08

Influenza Reagent

13/238 Anti-EV71 serum LOW (WHO International Reference Reagent)

WHO International Standard

13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard

Working Standard

13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).

WHO International Standard

13/248 Influenza virus infectious NIBRG-267

Influenza Reagent

13/250 Influenza Virus Infectious NIBRG-268

Influenza Reagent

13/252 Influenza virus infectious NYMC X-223A

Influenza Reagent

13/256 Influenza virus infectious. NYMC x-233

Influenza Reagent

13/258 Influenza virus infectious NYMC X-233A

Influenza Reagent

13/264 Influenza Virus Infectious NYMC X-223

Influenza Reagent

13/B627-05 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1

Quality Control Reagent

13/B629-05 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1

Quality Control Reagent

13/B634-04 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2

Quality Control Reagent

13/B636-05 QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2

Quality Control Reagent

13/B640-02 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5

Quality Control Reagent

13/B642-07 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1

Quality Control Reagent

13/B644-03 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3

Quality Control Reagent

13/B650-02 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1

Quality Control Reagent

14/106 Influenza virus infectious. NYMC BX-51B

Influenza Reagent

14/114 JC Virus (JCV) DNA (1st International Standard)

WHO International Standard

14/116 Influenza virus infectious NYMC X-179A

Influenza Reagent

14/118 Influenza virus infectious B/Massachusetts/2/2012

Influenza Reagent

14/140 1st International Standard for Anti EV71 Serum Human

WHO International Standard

14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)

Influenza Reagent

14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)

Influenza Reagent

14/148 Human Blood Factor IX Concentrate (5th International Standard).

WHO International Standard

14/150 Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)

WHO International Standard

14/156 Meningococcal group X polysaccharide (1st WHO International Standard)

WHO International Standard

14/160 High titre anti-A in IVIG working reference reagent

Working Standard

14/174 Botulinum Type A Antitoxin, Equine

Non WHO Reference Material

14/198-003 HBV,HCV,HIV Multiplex

CE Marked Material

14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)

Influenza Reagent

14/204 Influenza Virus Infectious B/Brisbane/9/2014

Influenza Reagent

14/206 Influenza virus infectious NYMC X-247

Influenza Reagent

14/210 Biological activities of Rituximab WHO 1st International Standard

WHO International Standard

14/212 BK Virus (BKV)(1st International Standard)

WHO International Standard

14/224 Influenza virus infectious. A/Switzerland/9715293/2013

Influenza Reagent

14/226 Influenza Virus Infectious A/South Australia/55/2014

Influenza Reagent

14/228 Influenza Virus Infectious A/Stockholm/6/2014

Influenza Reagent

14/230 Influenza Virus Infectious. A/Norway/466/2014

Influenza Reagent

14/232 Influenza Virus Infectious IVR-175

Influenza Reagent

14/240-005 British Working Standard for Anti-HCV

CE Marked Material

14/242-003 Anti-HCV (1 in 8 dilution)(British Working Standard)

CE Marked Material

14/246 Influenza Virus Infectious NIBRG-301

Influenza Reagent

14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)

Influenza Reagent

14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)

Influenza Reagent

14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification

Non WHO Reference Material

14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).

WHO International Standard

14/306 Influenza Virus Infectious NYMC X-243 40180 E13

Influenza Reagent

14/308 Influenza Virus Infectious IVR-178 40200 E7

Influenza Reagent

14/314 Influenza Virus Infectious NIB-88

Influenza Reagent

14/316 Factor IX activated (FIXa) 2nd WHO International Standard

WHO International Standard

14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)

Influenza Reagent

14/320 Influenza Virus Infectious B/Utah/9/2014

Influenza Reagent

14/322 Influenza Virus Infectious NIB-91

Influenza Reagent

14/B651-02 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2

Quality Control Reagent

14/B653-02 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3

Quality Control Reagent

14/B654-03 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1

Quality Control Reagent

14/B655-03 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1

Quality Control Reagent

15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)

Influenza Reagent

15/102 Activated Blood Coagulation Factor X (FXa), Human

International Reference Reagent

15/104 Influenza Antigen A/South Australia/55/2014 Cell derived

Influenza Reagent

15/106 Ancrod

WHO International Standard

15/126 Bordetella pertussis toxin (20μg). (2nd International Standard)

WHO International Standard

15/130-001 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)

Clinical Virology Network CVN

15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum

Influenza Reagent

15/136 EBOV RNA NP-VP35-GP in-run control

International Reference Reagent

15/138 EBOV RNA VP40-L in-run control

International Reference Reagent

15/140 Batroxobin

Non WHO Reference Material

15/146 Influenza Virus Infectious B/Brisbane/60/2008

Influenza Reagent

15/148 Influenza Virus Infectious NIB-92

Influenza Reagent

15/150 Influenza anti-B/Phuket/3073/2013 HA serum

Influenza Reagent

15/154 Influenza Virus Infectious NIB-93

Influenza Reagent

15/158 Influenza Virus Infectious NYMC X-263

Influenza Reagent

15/160 Influenza Virus Infectious NIBRG-306

Influenza Reagent

15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent

International Reference Reagent

15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)

WHO International Standard

15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate

Working Standard

15/184 Influenza Virus Infectious NYMC X-263B

Influenza Reagent

15/188 Influenza Virus Infectious NYMC X-263A

Influenza Reagent

15/192 Influenza Virus Infectious A/Hong Kong/4801/2014

Influenza Reagent

15/194 Influenza Virus Infectious NYMC X-257A

Influenza Reagent

15/196 Influenza Virus Infectious NYMC X-261

Influenza Reagent

15/212 Influenza Virus Infectious NYMC BX-53C

Influenza Reagent

15/220 Anti-EBOV plasma, human (WHO Reference Reagent)

International Reference Reagent

15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)

International Reference Reagent

15/224 EBOV RNA VP40-L (WHO Reference Reagent)

International Reference Reagent

15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7

Influenza Reagent

15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)

Influenza Reagent

15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)

WHO International Standard

15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)

WHO International Standard

15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)

Influenza Reagent

15/250 Influenza Virus Infectious NYMC BX-31

Influenza Reagent

15/252 Influenza Virus Infectious A/California/7/2009

Influenza Reagent

15/262 Anti- EBOV Convalescent Plasma Pool - Sierra Leone (International Reference Reagent)

International Reference Reagent

15/266 HHV-6 Virus 1st WHO International Standard

WHO International Standard

15/274 Influenza Virus Infectious NYMC BX-59A

Influenza Reagent

15/294 Influenza virus infectious NYMC BX-59B

Influenza Reagent

15/298 Influenza Virus Infectious B/Brisbane/46/2015

Influenza Reagent

15/300 Influenza Virus Infectious NYMC BX-35 41950 E11

Influenza Reagent

15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard

WHO International Standard

15/312 Influenza Anti-B/Brisbane/60/2008 HA Serum

Influenza Reagent

15/B658-03 QCRLYMEQC1 - Anti-Lyme QC1

Quality Control Reagent

15/B661-04 QCRLYMEIgMQC1 - IgM Anti-Lyme QC1

Quality Control Reagent

15/B664-02 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1

Quality Control Reagent

15/B667-03 QCRMEASQC1 Anti-MeaslesQC1

Quality Control Reagent

15/B669-02 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1

Quality Control Reagent

15/B671-02 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1

Quality Control Reagent

15/B673-02 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1

Quality Control Reagent

15/B675-03 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2

Quality Control Reagent

15/B678-02 QCRPARVB19QC1 Anti-Parvovirus B19QC1

Quality Control Reagent

15/B680-01 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1

Quality Control Reagent

16/104-001 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques

Clinical Virology Network CVN

16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)

Influenza Reagent

16/108 Influenza Virus Infectious A/PR/8/34

Influenza Reagent

16/110-001 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)

Clinical Virology Network CVN

16/114 Influenza anti - A/California/7/09 HA serum

Influenza Reagent

16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)

Influenza Reagent

16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F

WHO International Standard

16/124-001 Zika Virus run Control (NAT)

Clinical Virology Network CVN

16/126 Native Vi polysaccharide (S. Typhi)

WHO International Standard

16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard

WHO International Standard

16/158 Influenza Antigen B/Phuket/3073/2013

Influenza Reagent

16/166 Diphtheria Antitoxin Equine DI.

WHO International Standard

16/170 Infliximab(1st International Standard)

WHO International Standard

16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum

Influenza Reagent

16/192 Influenza Anti-B/Brisbane/60/2008 HA serum

Influenza Reagent

16/194 HIV-1 RNA (4th International Standard)

WHO International Standard

16/200 Influenza Virus Infectious NIB-58

Influenza Reagent

16/208 Influenza Virus Infectious NIB-97 42090 E7

Influenza Reagent

16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)

Influenza Reagent

16/242 Influenza Virus Infectious NIB-98 42110 E7

Influenza Reagent

16/248 Influenza Virus Infectious NYMC X-275 42020 E11

Influenza Reagent

16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations

WHO International Standard

16/268 Influenza Virus Infectious X-273

Influenza Reagent

16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1

Influenza Reagent

16/274 Influenza Virus Infectious X-275A 42010 E13

Influenza Reagent

16/282 Influenza Virus Infectious X-285 42430 ExE1

Influenza Reagent

16/284 Antiserum to Respiratory Syncytial Virus WHO 1st International Standard

WHO International Standard

16/286 Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)

Influenza Reagent

16/288 Influenza Virus Infectious X-283A 42420 ExE1

Influenza Reagent

16/290 Influenza Virus Infectious X-285A 42440 ExE1

Influenza Reagent

16/292 Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)

Influenza Reagent

16/298 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)

Influenza Reagent

16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel)

International Reference Preparation

16/354 Influenza Virus Infectious A/Michigan/45/2015 41710 E4

Influenza Reagent

16/360 Influenza Virus Infectious NIB-96 41920 E7

Influenza Reagent

16/362 Influenza Virus Infectious NYMC X-291 42530 E8

Influenza Reagent

16/366 Influenza Virus Infectious NYMC X-291A 42540 E8

Influenza Reagent

16/376 Plasmodium falciparum antigens (1st International Standard)

WHO International Standard

16/B683-04 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1

Quality Control Reagent

16/B685-03 QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2

Quality Control Reagent

16/B687-01 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices

Quality Control Reagent

16/B693-01 QCRCMVIgMQC1 IgM Anti-CMV QC1

Quality Control Reagent

16/B695-01 QCRTOXOIgMQC1 IgM Anti-Toxoplasma gondii QC1

Quality Control Reagent

16/B704-01 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

Quality Control Reagent

16/B706-01 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

Quality Control Reagent

17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum

Influenza Reagent

17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1

Influenza Reagent

17/136 Influenza Virus Infectious NIBRG-375

Influenza Reagent

17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)

Influenza Reagent

17/156 Influenza Virus Infectious CNIC-1701 42910 E9

Influenza Reagent

17/162 Influenza Virus Infectious NYMC X-299 42920 E10

Influenza Reagent

17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5

Influenza Reagent

17/184 Influenza Virus Infectious NIB-103 42610 E7

Influenza Reagent

17/194 Influenza Virus Infectious NIB-104

Influenza Reagent

17/196 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016

Influenza Reagent

17/210 Influenza Virus Infectious IVR-186 43310 E8

Influenza Reagent

17/218 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)

Influenza Reagent

17/220 Influenza anti-A/Singapore/INFIMH-16-0019/2016-like HA serum)

Influenza Reagent

17/248 Influenza Virus Infectious B/Phuket/3073/2013

Influenza Reagent

17/252 Influenza Virus Infectious NYMC BX-69 43220 E13

Influenza Reagent

17/B710-02 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1

Quality Control Reagent

17/B717-01 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1

Quality Control Reagent

17/B718-01 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2

Quality Control Reagent

234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)

Non WHO Reference Material

2BADS Anti-Brucella Abortus Serum, Bovine (International Standard)

WHO International Standard

2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard)

WHO International Standard

2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)

WHO International Standard

520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)

Non WHO Reference Material

59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine

Non WHO Reference Material

59/016 Corticotrophin (ACTH), Porcine (3rd International Standard)

WHO International Standard

59/021 Botulinum Antitoxin Equine Type A

Non WHO Reference Material

60/001 Botulinum Antitoxin Equine Type B

Non WHO Reference Material

60/013 Tetanus Antitoxin, Equine, for Bioassay

Non WHO Reference Material

61/001 Botulinum Antitoxin Equine Type D (1st International Standard)

WHO International Standard

62/001 Serum Gonadotrophin, Equine (2nd International Standard)

WHO International Standard

62/014 Lysine Vasopressin, Porcine

Non WHO Reference Material

63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine

Non WHO Reference Material

63/007 Diphtheria Antitoxin, Equine, for Flocculation Test

Non WHO Reference Material

64/002 Rheumatoid Arthritis Serum

Non WHO Reference Material

64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine

Non WHO Reference Material

64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine

Non WHO Reference Material

65/093 Anti-Thyroglobulin Serum, Human (International Reference reagent)

International Reference Preparation

以上为"NIBSC 67/099免疫球蛋白 IgG IgA IgM Immunoglobulins G, A"供应信息
相关推荐